Myocarditis as a complication of a new coronavirus infection in medical workers (clinical observations)

The study of various pathological conditions associated with COVID-19 remains an urgent task. The most important manifestation of COVID-19 is the defeat of the cardiovascular system, one of the possible variants of which may be the development of myocarditis.

Medical workers are at an increased risk of infection with the SARS-CoV-2 virus. A new coronavirus infection in medical workers can be considered an occupational disease if the infection occurred while they were performing their professional duties.

The study aims to describe two clinical observations of myocarditis associated with a new coronavirus infection in medical workers, with the establishment of its causal relationship with professional activity.

The article presents a description of a moderate variant of the course of covid-associated myocarditis in medical workers with cardiac arrhythmia in the form of ventricular extrasystole, the development of chronic heart failure. There is a need for a multidisciplinary approach to the diagnosis and treatment of COVID-19 manifestations with the mandatory participation of a cardiologist, advanced training in the field of COVID-19 communication, taking into account complications and peculiarities of working conditions of medical workers.

Ethics. The study was conducted in compliance with Ethical principles and with the voluntary informed consent of the participants.

Contribution:
Strizhakov L.A. — concept and design of the study, editing;
Babanov S.A. — concept and design of the study, the text writing;
Gulyaev S.V. — concept and design of the study, the text writing, editing;
Azovskova T.A. — concept and design of the study, data collection and processing, the text writing;
Konovalov D.V. — data collection and processing, the text writing;
Lavrentieva N.E. — data collection and processing, the text writing, editing;
Baraeva R.A. — data collection and processing, editing.

Funding. The study had no funding.

Conflict of interests. The authors declare no conflict of interests.

Received: 22.05.2023 / Accepted: 07.09.2023 / Published: 05.11.2023

1. Bukhtiyarov I.V. Epidemiological, clinical, and expert problems of occupational infectious diseases of workers during medical care in the COVID-19 pandemic. Med. truda i prom ekol. 2021; 61(1): 4–12 https://doi.org/10.31089/1026-9428-2021-61-1-4-12 (in Russian).

2. Temporary guidelines "Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)". Version 15 (02/22/2022).

3. New coronavirus infection COVID-19: professional aspects of maintaining the health and safety of medical workers: methodological recommendations. Eds. I.V. Bukhtiyarov, Yu.Yu. Gorblyansky. 2nd ed., revised and supplemented. M.: AMT, IRIOH; 2022.

4. Burdorf A., Porru F., Rugulies R. The COVID‑19 (Coronavirus) pandemic: Consequences for occupational health. Scand. J. Work Environ. Health. 2020; 46(3): 229–230. https://doi.org/10.5271/sjweh.3893

5. Garipova R.V., Strizhakov L.A., Gorblyansky Yu.Yu., Babanov S.A. New coronavirus infection as an occupational disease: complex expert cases. Med. truda i prom ekol. 2021; 61(11): 720–725. https://doi.org/10.31089/1026-9428-2021-61-11-720-725 (in Russian)

6. On the state of sanitary and epidemiological well-being of the population in the Samara region in 2020. State report. S.: Office of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare in the Samara Region. Center for Hygiene and Epidemiology in the Samara Region; 2020: 99–101.

7. Babanov S.A., Azovskova T.A., Dudintseva N.V. Analysis of occupational morbidity in the Samara region in 2017–2021. Nauchno-prakticheskij retsenziruemyj zhurnal "Sovremennye problemy zdravookhraneniya i meditsinskoj statistiki". 2022; 3: 336–354. https://doi.org/10.24412/2312-2935-2022-3-336-354

8. Long B., Brady W.J., Koyfman A. et al. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020; 18: 1–4. https://doi.org/10.1016/j.ajem.2020.04.048

9. Xiong T.Y., Redwood S., Prendergast B., Chen M. Coronaviruses and the cardiovascular system: acute and longterm implications. Eur Heart J. 2020; 2: 1–3. https://doi.org/10.1093/eurheartj/ehaa231

10. Ho J.S., Sia C.H., Chan M.Y. et al. Coronavirus-induced myocarditis: A meta-summary of cases. Heart Lung. 2020; 49(6): 681–685. https://doi.org/10.1016/j.hrtlng.2020.08.013

11. Shpagina L.A., Kuzmina L.P., Kotova O.S., Shpagin I.S., Kamneva N.V., Kuznetsova G.V., Likhenko-Logvinenko K.V. COVID-19 in healthcare workers (literature review and own data). Med. truda i prom ekol. 2021; 61(1): 18–26. (In Russ.) https://doi.org/10.31089/1026-9428-2021-61-1-18-26

12. Goha A., Mezue K., Edwards P. et al. COVID-19 and the heart: An update for clinicians. Clin Cardiol. 2020; 43(11): 1216–1222. https://doi.org/10.1002/clc.23406

13. Kariyanna P.T., Sutarjono B., Grewal E. et al. A Systematic Review of COVID-19 and Myocarditis. Am. J. Med Case Rep. 2020; 8(9): 299–305. https://doi.org/10.12691/ajmcr-8-9-11

14. Pirzada A., Mokhtar A.T., Moeller A.D. COVID-19 and Myocarditis: What Do We Know So Far? CJC Open. 2020; 2(4): 278–285. https://doi.org/10.1016/j.cjco.2020.05.005

15. Chen L., Li X., Chen M. et al. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020; 116: 1097–1100. https://doi.org/10.1093/cvr/cvaa078

16. Verdecchia P., Cavallini C., Spanevello A., Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur. J. Intern. Med. 2020; 76: 14–20. https://doi.org/10.1016/j.ejim.2020.04.037

17. Zhang H., Penninger J.M., Li Y. et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intens. Care Med. 2020; 46: 586–590. https://doi.org/10.1007/s00134-020-05985-9

18. Li J., Gao J., Xu Y.P., et al. Expression of severe acute respiratory syndrome coronavirus receptors, ACE2 and CD209L in different organ derived microvascular endothelial cells. Zhonghua Yi Xue Za Zhi. 2007; 87(12): 833–837.

19. Ludwig R.J., Vanhoorelbeke K., Leypoldt F., et al. Mechanisms of autoantibodyinduced pathology. Front Immunol. 2017; 8: 603.

20. Vabret N., Britton G.J., Gruber C., et al. Immunology of COVID-19: Current state of the science. Immunity. 2020; 52(6): 910–41.

21. Weatherhead J.E., Clark E., Vogel T.P., et al. Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum. J. Clin. Invest. 2020; 130(12): 6194–7.

22. Song W.-C., FitzGerald G.A. COVID-19, microangiopathy, hemostatic activation, and complement. J. Clin. Invest. 2020; 130(8): 3950-53.

23. Wenzhong L., Hualan L. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. ChemRxin. https://doi.org/10.26434/chemrxiv.11938173.v8

24. Pascolini S., Vannini A., Deleonardi G., et al. COVID-19 and immunological dysregulation: can autoantibodies be useful? Clin Transl Sci. 2021; 14(2): 502–508.

25. Belyakov N.A., Rassokhin V.V., Yastrebova E.B. Coronavirus infection COVID-19. Nature of the virus, pathogenesis, clinical manifestations. Soobshhenie 1. VICH-infektsiya i immunosupressii. 2020; 12(1): 7–21. https://doi.org/10.22328/2077-9828-2020-12-1-7-21

26. Castiello T., Georgiopoulos G., Finocchiaro G. et al. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail Rev. 2021; 27(1): 251–261. https://doi.org/10.1007/s10741-021-10087-9

27. Sergeeva V.A., Lipatova T.E. Myocarditis due to COVID-19: clinical features and drug treatment. RMJ. Meditsinskoe obozrenie. 2022; 6(1): 26–32. https://doi.org/10/32364/2587-6821-2022-6-1-26-32

28. Caforio A.L., Pankuweit S., Arbustini E. et al. European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34(33): 2636–2648. https://doi.org/10.1093/eurheartj/eht210

29. Cinar T., Hayiroglu M.I., Cicek V. et al. COVID-19 and acute myocarditis: current literature review and diagnostic challenges. Rev Assoc Méd Bras. 2020; 66(2): 48–54. https://doi.org/10.1590/1806-9282.66.S2.48

30. Ignatieva E.S., Ryzhkova D.V., Mitrofanova L.B., Moiseeva O.M. Possibilities of magnetic resonance imaging in the diagnosis of various clinical and morphological forms of myocarditis. Rossijskij kardiologicheskij zhurnal. 2017; 2(142): 30–38. https://doi.org/10.15829/1560-4071-2017-2-30-38

31. Practice of echocardiography during the COVID-19 pandemic: guidance from the Canadian Society of Echocardiography (Electronic resource.) https://clck.ru/362zxS (access date: 15.10.2021).